Trial Profile
Phase I trial of UCB 0942 for refractory epilepsy.
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 17 Mar 2011
Price :
$35
*
At a glance
- Drugs Padsevonil (Primary)
- Indications Epilepsy
- Focus Adverse reactions
- Sponsors UCB
- 17 Mar 2011 New trial record